Status:
COMPLETED
COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Sars-CoV2
Eligibility:
All Genders
Phase:
NA
Brief Summary
The epidemic due to the Sars-CoV2 virus is spreading in France, without knowning precisely since when the virus has actually circulated on the territory. Data from China but also systematic samples ta...
Detailed Description
The epidemic due to Sars-CoV2 is spreading in France, without it being knowning precisely since when the virus actually circulated on the territory. Data from China but also systematic samples taken f...
Eligibility Criteria
Inclusion
- Any permanent medical or paramedic staff of participating services who have given written consent to participate
- Having a social security insurance.
Exclusion
- Non-permanent staff (occasional staffing), administrative staff, technical staff of participating services.
- Staff who were not active during the inclusion period.
Key Trial Info
Start Date :
March 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 7 2021
Estimated Enrollment :
1177 Patients enrolled
Trial Details
Trial ID
NCT04304690
Start Date
March 16 2020
End Date
July 7 2021
Last Update
July 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Pitié Salpetrière
Paris, France, 75013